Scientists identify compound that boosts effects of Taxol, other drugs
Diseases
OMRF offers unique benefit to employees: Breast cancer risk assessment testing program helps workers make key health decisions
In today’s workplace, insurance and retirement benefits are expected. Health insurance, dental and vision plans are commonplace as well. But at OMRF, employees and their families can take advantage of a unique employee benefit—a breast cancer risk assessment test. On Friday, 80 women—OMRF employees and spouses—will take the OncoVue breast cancer risk assessment test. This […]
OMRF offers scholarships for state science teachers
OMRF is offering scholarships for Oklahoma science teachers to participate in its 2009 Foundation Scholar Program. For two decades, OMRF’s Foundation Scholar Program has helped Oklahoma science teachers build their classroom curriculum through hands-on laboratory work and interaction with scientists and other educators. Scholarships provide a $2,000 stipend plus housing (if needed) and $1,000 in […]
Hiding in Plain Sight OMRF researchers discover rogue immune cells in healthy adults
A new study from OMRF has discovered that lurking in the bodies even of healthy people are numerous rogue immune cells, the cause of rheumatoid arthritis and a host of other diseases. The new findings could be key to developing new ways to prevent and treat autoimmune diseases, conditions like rheumatoid arthritis, lupus and type […]
Inaugural Putnam City Cancer Classic to raise money for research at OMRF
For 33 years, the students, parents and teachers of the Putnam City School District have made cancer Public Enemy No. 1. If there’s a way to raise money, Putnam City has done it; from carnivals to bake sales to door-to-door fund drives. This year, the schools have added another weapon to the arsenal—a 5-kilometer run/walk. […]
Survivor Story: Sandy Roark
Sandy Roark was suffering from a rare, life-threatening disease. A pair of OMRF scientists bent on solving a medical mystery. Sometimes hope is closer than you think.
